Fenofibrate 145 mg Tablet (Fibofen-145)

Fenofibrate 145 mg — Lipid-Lowering Tablet

Fibofen-145 Tablet — Fenofibrate 145 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Fenofibrate 145 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Blister)
MRP ₹ 1250
Therapy Cardiac + Diabetic — PPAR-alpha agonist (fibrate)
Storage Store below 25°C.

WhatsApp EnquiryCall: +919041677932

More in the Fibofen range from Trumac Healthcare

Brand Composition Pack
FIBOFEN-160 Tablet – Fenofibrate 160mg TabletsFIBOFEN-160 Tablet Fenofibrate 160mg Tablets 10 x 10 (Blister)

All available for PCD franchise on a monopoly basis and as wholesale stock. WhatsApp +91 90416 77932 for net rates.

For chemists, distributors and doctors: Fibofen-145 (fenofibrate 145 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

Buying this composition for PCD franchise, wholesale or under your own brand? See Fenofibrate 145 mg Tablet – manufacturer, supplier & PCD franchise for available packs and brand options.

See the full cardiac tablets range – manufacturer, supplier and PCD franchise: telmisartan, olmesartan, amlodipine, metoprolol, rosuvastatin, atorvastatin, clopidogrel, ticagrelor, trimetazidine and their combinations.

About Fibofen-145 Tablet

Fibofen-145 Tablet contains Fenofibrate 145 mg in a nanocrystalline formulation that provides good bioavailability with or without food. Fenofibrate is a peroxisome-proliferator-activated-receptor (PPAR)-alpha agonist with potent triglyceride-lowering and modest HDL-raising effects.

It is indicated for severe hypertriglyceridaemia, mixed dyslipidaemia, low-HDL states, diabetic dyslipidaemia and as adjunct to statins in patients with persistent triglyceride elevation.

Camrut Healthcare manufactures Fibofen-145 under WHO-GMP conditions for PCD pharma franchise across India.

Looking up another Trumac medicine? See what every Trumac Healthcare brand is used for – A–Z in English and Hindi: Trumac Healthcare tablet uses. Take medicines only as your doctor prescribes.

Indications

  • Severe hypertriglyceridaemia (TG > 500 mg/dL)
  • Mixed dyslipidaemia
  • Low HDL cholesterol with high triglycerides
  • Diabetic dyslipidaemia
  • Adjunct to statins in residual hypertriglyceridaemia

Mechanism of Action

Fenofibrate activates PPAR-alpha, a nuclear transcription factor regulating lipid metabolism genes. This increases lipoprotein lipase activity (clearing triglyceride-rich particles), decreases apoC-III (an LPL inhibitor) and increases apoA-I synthesis (raising HDL). Net effects: 30–50% reduction in triglycerides and modest 5–20% increase in HDL.

Dosage & Administration

  • Adults: 1 tablet (145 mg) once daily, with or without food
  • Take with adequate water
  • Monitor lipids every 3 months
  • Periodic monitoring of liver function and CK

Side Effects

  • Mild GI upset
  • Myalgia and muscle weakness
  • Elevated liver enzymes
  • Increased serum creatinine
  • Cholelithiasis with prolonged use

Contraindications & Precautions

  • Severe hepatic impairment
  • Severe renal impairment (eGFR < 30)
  • Pre-existing gallbladder disease
  • Hypersensitivity to fenofibrate
  • Pregnancy and breastfeeding

Storage

Store below 25°C.

From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare cardiac diabetic PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.

PCD Pharma Franchise & Third-Party Manufacturing
Fibofen-145 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.